Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: Short- and long-term outcomes

Olga Frankfurt*, Shuo Ma, Leo Gordon, Jane N. Winter, Jeanne M. Horowitz, Alfred Rademaker, Bing Bing Weitner, Loann C. Peterson, Jessica K. Altman, Martin S. Tallman, Adam Petrich, Steven T. Rosen

*Corresponding author for this work

Research output: Contribution to journalArticle

10 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: Short- and long-term outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences